REGN Jun 2024 560.000 call
| Previous close | 244.50 |
| Open | 244.50 |
| Bid | 300.00 |
| Ask | 309.00 |
| Strike | 560.00 |
| Expiry date | 2024-06-21 |
| Day's range | 244.50 - 244.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
Insider MonkeyThe Biggest Biotechnology Company in Europe
We’ve recently covered a list of 20 Biggest Publicly-Traded Biotech Companies based on market caps that you can visit here. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering $3.88 trillion by 2030. The […]
Insider MonkeyThe Biggest Publicly Traded Biotech Company
In this article, we will be discussing the biggest publicly traded biotech company that ranks at the top of our free list of the 20 Biggest Publicly Traded Biotech Companies. Biotechnology and Industry 2023: Market Growth, Transformations, and Technological Milestones The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate […]
ZacksRegeneron (REGN) Announces Positive Data on Oncology Candidate
Regeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor responses in patients with microsatellite-stable colorectal cancer.
